Company: PAII-WT
Filing Date: 2025-05-29
Form Type: DRS
Source: 0001213900-25-049013
Chunk: 265

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-05-29
Form: DRS
Chunk 265
---
 exercise its warrants only for a whole number of the company’s Class A ordinary shares. This means only a whole warrant may be exercised at any given time by a warrant holder. For example, if a warrant holder holds one -halfof one warrant to purchase a Class A ordinary share, such warrant will not be exercisable. If a warrant holder holds two halves of one warrant, such whole warrant will be exercisable for one Class A ordinary share at a price of $11.50 per share. The Class A ordinary shares and warrants comprising the units are expected to begin separate trading on the NYSE on the 52 ndday following the date of this prospectus unless UBS, as the representative of the underwriters, informs us of its decision to allow earlier separate trading, subject to our having filed the Current Report on Form 8 -Kdescribed below and having issued a press release announcing when such separate trading will begin. Once the Class A ordinary shares and warrants commence separate trading, holders will have the option to continue to hold units or separate their units into the component securities. Holders will need to have their brokers contact our transfer agent in order to separate the units into Class A ordinary shares and warrants. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant. In no event will the Class A ordinary shares and warrants be traded separately until we have filed with the SEC a Current Report on Form 8 -Kwhich includes an audited balance sheet reflecting our receipt of the gross proceeds of this offering. We will file a Current Report on Form 8 -Kwhich includes this audited balance sheet upon the completion of this offering. If the over -allotmentoption is exercised following the initial filing of such Current Report on Form 8 -K, a second or amended Current Report on Form 8 -Kwill be filed to provide updated information to reflect the exercise of the over -allotmentoption. Ordinary shares Prior to the date of this prospectus, there were 7,255,952 Class B ordinary shares outstanding, all of which were held of record by our initial shareholders, so that our initial shareholders will own 26.5% of our issued and outstanding shares after this offering (assuming our initial shareholders do not purchase any units in this offering). Up to 946,428 of the founder shares will be surrendered for no consideration depending on the extent to which the